TOG Review (RCOG Journal)

MRCOG Part 2

Sexual and Reproductive Health

Contraceptive methods and issues around the menopause

Key Statistics

  • 1 in 5 — Pregnancies ≥40y unplanned (NATSAL)
  • 6× — ↑VTE risk with CHC
  • 50/55y — Stop non-hormonal/all contraception age

Don't-miss facts

  1. No contraceptive method is contraindicated on age alone up to age 50y

  2. Stop rules: ≥50y non-hormonal – 1yr amenorrhoea; <50y – 2yr; on POP/implant/IUS ≥50y – 1yr after 2×FSH >30 IU/l (≥6wk apart); or stop at 55y

  3. Sequential HRT inhibits ovulation in only 40% – NOT contraceptive; only 52 mg IUS gives licensed endometrial protection with HRT

  4. CHC VTE risk up to 6× baseline (2/10,000/yr); continuous use safer than stop–start (risk rises again after ≥1 month break)

  5. Nexplanon® = most effective reversible method, 3 years, no BMD effect, effective to 149 kg

  6. Depo Provera®: ~5% bone loss in first 2 years; FSRH – consider stopping at 50y

  7. EC: LNG to 72h, UPA to 120h, copper IUD most effective (always offer); avoid progestogen contraception for 5 days post- UPA

  8. Sterilisation failure: female 1:200, vasectomy 1:2000; counsel on LARC alternatives first

Failure rates (typical use, %/year)

Implant 0.05 IUS 0.2 IUD 0.8 Injectable 6.0 CHC 9.0 POP 9.0

Abbreviation Key

  • WHO — World Health Organization
  • UKMEC — UK Medical Eligibility Criteria
  • FSH — follicle stimulating hormone
  • HMB — heavy menstrual bleeding
  • FSRH — Faculty of Sexual and Reproductive Healthcare
  • STI — sexually transmitted infection
  • HRT — hormone replacement therapy
  • PID — pelvic inflammatory disease
  • IUC — intrauterine contraception
  • ALO — actinomyces-like organism
  • IUS — intrauterine system
  • EC — emergency contraception
  • IUD — intrauterine device
  • LNG — levonorgestrel
  • IUB — intrauterine ball
  • UPA — ulipristal acetate
  • LARC — long-acting reversible contraception
  • UPSI — unprotected sexual intercourse
  • CHC — combined hormonal contraception
  • PRM — progesterone receptor modulator
  • POP — progestogen-only pill
  • NATSAL — National Survey of Sexual Attitudes and Lifestyles
  • VTE — venous thromboembolism
  • NICE — National Institute for Health and Care Excellence
  • OR — odds ratio

Source: Bakour SH, Hatti A, Whalen S. Contraceptive methods and issues around the menopause: an evidence update. The Obstetrician & Gynaecologist 2017;19:289–97. doi:10.1111/tog.12416

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free